Glimpse Group, Inc. (GGRP): Nasdaq/NYSE listing notice — Glimpse Group receives Nasdaq deficiency notice for bid price below $1.00

Glimpse Group, Inc.

Closing bid price below $1.00 for 30 consecutive business days triggers non-compliance letter from Nasdaq.
Company has 180 calendar days until September 9, 2026 to regain compliance.
Compliance can be regained if bid price closes at or above $1.00 for at least 10 consecutive business days.
If not cured, company may get second 180-day period if it meets other listing standards and plans reverse split.
No immediate effect on listing; shares continue trading under GGRP on Nasdaq Capital Market.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Glimpse Group, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

March 13, 2026, The Glimpse Group, Inc. (the “Company”) received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, because the closing bid price for the Company’s common stock listed on Nasdaq was below $1.00 for the prior 30 consecutive business days, the Company no longer meets the minimum bid price requirement for continued listing on the Nasdaq Capital Market under Nasdaq Marketplace Rule 5550(a)(2), requiring a minimum bid price of at least $1.00 per share (the “Minimum Bid Price Requirement”). The notifi

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Glimpse Group, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-011277

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.